PartnershipUpdated on 27 March 2025
Partner with Scope Biosciences on CRISPR-based Diagnostic Co-Development
About
Scope Biosciences offers a modular CRISPR-based diagnostics platform that enables rapid, ultra-specific molecular testing at the point-of-care. We are seeking strategic partners interested in co-developing tailored assays for clinical or applied use cases. Lets combine your market insight with our technology to bring powerful diagnostics to the field.
Looking for
- Development
Organisation
Similar opportunities
Investment
Invest in the Future of CRISPR Diagnostics
- Startup
- Agriculture & Food
- Speed and Development
- Health Biotechnology
- Growth and Establishment
Niek Savelkoul
CEO at Scope Biosciences B.V.
Wageningen, Netherlands
Partnership
Partner with Diagnostic Imagery Start-up
- Development
Daniel Horgan
Director of Admissions at Scotia
Tralee, Ireland
Investment
- Startup
- AI, Data & ICT
- Medical Technologies
Daniel Horgan
Director of Admissions at Scotia
Tralee, Ireland